Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US-Reference-Cited by-同舟云学术

Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US

Published:2022-03-21 Issue:1 Volume:25 Page:309-320
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Fanikos John¹^ORCID,Goldstein Joshua N.²^ORCID,Lovelace Belinda³^ORCID,Beaubrun Anne C.³^ORCID,Blissett Robert S.⁴^ORCID,Aragão Filipa⁴⁵^ORCID

Affiliation:

1. Brigham and Women’s Hospital, Boston, MA, USA

2. Massachusetts General Hospital, Boston, MA, USA

3. Alexion, AstraZeneca Rare Disease, Boston, MA, USA

4. Maple Health Group, LLC, New York, NY, USA

5. NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal

Funder

Portola Pharmaceuticals, Inc

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2042106

Reference57 articles.

1. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

2. Antithrombotic Therapy for VTE Disease

3. Management of Factor Xa inhibitor-associated life-threatening major hemorrhage: A retrospective multi-center analysis

4. Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

5. Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study;Journal of Clinical Medicine;2024-07-21

2. Traumatic Brain Injury in Patients under Anticoagulant Therapy: Review of Management in Emergency Department;Journal of Clinical Medicine;2024-06-24

3. Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-05

4. Beware the counsel of the oracle;Journal of the American College of Emergency Physicians Open;2023-10

5. Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice;European Journal of Cardio-Thoracic Surgery;2023-10-01